Imaging-Based Prevalence of Oligometastatic Disease: A Single-Center Cross-Sectional Study
Sebastian M. Christ(University of Zurich), Matthias Gückenberger(University of Zurich), Martin W. Huellner(University of Zurich), Nicolaus Andratschke(University Hospital of Zurich), Anja Kühnis(University of Zurich), Maiwand Ahmadsei(University Hospital of Zurich), Jonas Willmann(University of North Texas), Eugenia Vlaskou Badra(University Hospital of Zurich), Urs J. Muehlematter(University of Zurich), Stephanie Kroeze(University Hospital of Zurich), Kaspar Pohl(University of Zurich), Michael Mayinger(University Hospital of Zurich), Philip Heesen(University of Zurich)
International Journal of Radiation Oncology*Biology*Physics
July 28, 2022
Cited by 28
Related Papers
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
|Annals of Oncology|2021|577